Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) — Market Cap & Net Worth
Market Cap & Net Worth: Park Ha Biological Technology Co., Ltd. (PHH)
Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) has a market capitalization of $13.04 Million ($13.04 Million) as of April 12, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31099 globally and #9561 in its home market, demonstrating a 2.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Park Ha Biological Technology Co., Ltd.'s stock price $0.39 by its total outstanding shares 33874403 (33.87 Million).
Park Ha Biological Technology Co., Ltd. Market Cap History: 2025 to 2025
Park Ha Biological Technology Co., Ltd.'s market capitalization history from 2025 to 2025. Data shows growth from $13.04 Million to $13.04 Million (0.00% CAGR).
Park Ha Biological Technology Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Park Ha Biological Technology Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PHH by Market Capitalization
Companies near Park Ha Biological Technology Co., Ltd. in the global market cap rankings as of April 12, 2026.
Key companies related to Park Ha Biological Technology Co., Ltd. by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #36 globally with a market cap of $339.20 Billion USD.
- The Procter & Gamble Company (SA:PGCO34): Ranked #38 globally with a market cap of $331.08 Billion USD ( R$1.69 Trillion BRL).
- L’Oreal SA (PA:OR): Ranked #82 globally with a market cap of $198.75 Billion USD ( €170.01 Billion EUR).
- Unilever PLC (PINK:UNLYF): Ranked #148 globally with a market cap of $131.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #36 | Procter & Gamble Company | NYSE:PG | $339.20 Billion | $145.16 |
| #38 | The Procter & Gamble Company | SA:PGCO34 | $331.08 Billion | R$51.86 |
| #82 | L’Oreal SA | PA:OR | $198.75 Billion | €358.90 |
| #148 | Unilever PLC | PINK:UNLYF | $131.81 Billion | $60.96 |
Park Ha Biological Technology Co., Ltd. Historical Marketcap From 2025 to 2025
Between 2025 and today, Park Ha Biological Technology Co., Ltd.'s market cap moved from $13.04 Million to $ 13.04 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $13.04 Million | -- |
End of Day Market Cap According to Different Sources
On Apr 12th, 2026 the market cap of Park Ha Biological Technology Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.04 Million USD |
| MoneyControl | $13.04 Million USD |
| MarketWatch | $13.04 Million USD |
| marketcap.company | $13.04 Million USD |
| Reuters | $13.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells produ… Read more